Down-regulation of E-cadherin and catenins in human pituitary growth hormone-producing adenomas.

No abstract is available for this paper.

• Publication year

  2004

• Venue

  Frontiers of Hormone Research

• Publication date

  2004-12-10

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1159/000079041PMID 15281343
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• β-Catenin mutation is selected during malignant transformation in colon carcinogenesis

  2003cited by this paper
• beta-Catenin mutation is selected during malignant transformation in colon carcinogenesis.

  2003cited by this paper
• Cribriform‐morular variant of papillary thyroid carcinoma: a pathological and molecular genetic study with evidence of frequent somatic mutations in exon 3 of the β‐catenin gene

  2003cited by this paper
• Neuroendocrine Carcinomas of the Pancreas With `Rhabdoid' Features

  2003cited by this paper
• Adenocarcinomas of the gastrointestinal tract with prominent rhabdoid features.

  2002cited by this paper
• Downregulation of E-cadherin and its undercoat proteins in pituitary growth hormone cell adenomas with prominent fibrous bodies

  2002cited by this paper
• Frequent nuclear accumulation of β‐catenin in pituitary adenoma

  2001cited by this paper
• Expression of intercellular adhesion molecules in epithelioid sarcoma and malignant rhabdoid tumor

  2001cited by this paper
• Accumulation of β-Catenin Protein and Mutations in Exon 3 of β-Catenin Gene in Gastrointestinal Carcinoid Tumor

  2001cited by this paper
• Frequent nuclear accumulation of beta-catenin in pituitary adenoma.

  2001cited by this paper
• Lung carcinoma with rhabdoid cells: a clinicopathological study and survival analysis of 14 cases

  2001cited by this paper
• Prognostic relevance of intracytoplasmic cytokeratin pattern, hormone expression profile, and cell proliferation in pituitary adenomas of akromegalic patients.

  2001cited by this paper
• Accumulation of beta-catenin protein and mutations in exon 3 of beta-catenin gene in gastrointestinal carcinoid tumor.

  2001cited by this paper
• Immunohistology of neuroendocrine and neuroectodermal tumors.

  2000cited by this paper
• Cytoskeletal proteins connecting intermediate filaments to cytoplasmic and nuclear periphery.

  1999cited by this paper
• Cadherins and their connections: adhesion junctions have broader functions.

  1999cited by this paper
• Cytokeratin 20: a marker for diagnosing Merkel cell carcinoma.

  1999cited by this paper
• Expression of epithelial cadherin and cavernous sinus invasion in human pituitary adenomas

  1997cited by this paper
• Growth hormone-induced reorganization of the actin cytoskeleton is not required for STAT5 (signal transducer and activator of transcription-5)-mediated transcription.

  1997cited by this paper
• Integration of intermediate filaments into cellular organelles.

  1996cited by this paper
• Plectin sidearms mediate interaction of intermediate filaments with microtubules and other components of the cytoskeleton

  1996cited by this paper
• Vimentin's tail interacts with actin-containing structures in vivo.

  1994cited by this paper
• Endocrine and morphological study of a clinically silent somatotroph adenoma of the human pituitary.

  1993cited by this paper
• Expression of glycoprotein hormones and intracytoplasmic distribution of cytokeratin in growth hormone-producing pituitary adenomas.

  1991cited by this paper
• Intermediate Filament Networks: Organization and Possible Functions of a Diverse Group of Cytoskeletal Elements

  1986cited by this paper
• Fibrous bodies in growth hormone-secreting adenomas contain cytokeratin filaments.

  1985cited by this paper
• Regulation of cytoskeletal architecture by platelet-derived growth factor, insulin and epidermal growth factor.

  1984cited by this paper
• Rearrangement of the keratin cytoskeleton after combined treatment with microtubule and microfilament inhibitors

  1983cited by this paper
• Ultrastructure of malignant rhabdoid tumor of the kidney. A distinctive renal tumor of children.

  1981cited by this paper
• Morphogenesis and significance of fibrous bodies in human pituitary adenomas

  1978cited by this paper

• A single-center prospective study evaluating the relationship of tumor consistency on remission in acromegaly patients

  2025cites this paper
• Clinical and prognostic significance of granulation patterns in somatotroph adenomas/tumors of the pituitary: a meta-analysis

  2023cites this paper
• The Prognostic-Based Approach in Growth Hormone-Secreting Pituitary Neuroendocrine Tumors (PitNET): Tertiary Reference Center, Single Senior Surgeon, and Long-Term Follow-Up

  2022cites this paper
• Prognostic Factors for Recurrence in Pituitary Adenomas: Recent Progress and Future Directions

  2022cites this paper
• Epithelial–Mesenchymal Transition in the Resistance to Somatostatin Receptor Ligands in Acromegaly

  2021cites this paper
• Cadherin Expression and EMT: A Focus on Gliomas

  2021cites this paper
• An Update on Pituitary Neuroendocrine Tumors Leading to Acromegaly and Gigantism

  2021cites this paper
• Quantitative proteomics revealed the molecular characteristics of distinct types of granulated somatotroph adenomas

  2021cites this paper
• Structure, Function, and Morphology in the Classification of Pituitary Neuroendocrine Tumors: the Importance of Routine Analysis of Pituitary Transcription Factors

  2020cites this paper
• Molecular profiling confirms historical immunohistochemistry in acromegaly.

  2020cites this paper
• Pituitary Adenoma Pathogenesis: The Presence Of E-Cadherin and Its Influence on Tumor Invasiveness

  2019cites this paper
• Germline and mosaic mutations causing pituitary tumours: genetic and molecular aspects.

  2019cites this paper
• Pathological markers of somatotroph pituitary neuroendocrine tumors predicting the response to medical treatment.

  2019cites this paper
• Molecular determinants of the response to medical treatment of growth hormone secreting pituitary neuroendocrine tumors.

  2019cites this paper
• Novel aspects in histopathology of the pituitary gland.

  2017cites this paper
• Elucidating the Role of the Desmosome Protein p53 Apoptosis Effector Related to PMP-22 in Growth Hormone Tumors

  2017cites this paper
• Pathology of GH-producing pituitary adenomas and GH cell hyperplasia of the pituitary

  2017cites this paper
• Novel aspects in histopathology of the pituitary gland.

  2017cites this paper
• Expression of E-cadherin, Slug and NCAM and its relationship to tumor invasiveness in patients with acromegaly

  2017cites this paper
• N-cadherin and vimentin expression in small rounded-shaped cells of non-functioning human pituitary adenomas

  2016cites this paper
• Differential somatostatin receptor (SSTR) 1-5 expression and downstream effectors in histologic subtypes of growth hormone pituitary tumors.

  2015cites this paper
• An algorithmic approach to sellar region masses.

  2015cites this paper
• Granulation pattern, but not GSP or GHR mutation, is associated with clinical characteristics in somatostatin-naive patients with somatotroph adenomas.

  2013cites this paper
• Expression and Significance of E-Cadherin and β-Catenins in Pituitary Adenoma

  2013cites this paper
• Clinical implications of growth hormone–secreting tumor subtypes

  2012cites this paper
• Indication of transsphenoidal surgery for lobulated pituitary adenomas

  2012cites this paper
• New directions in pharmacological treatment of acromegaly

  2009cites this paper
• Recent Clinical and Pathophysiological Advances in Non-Functioning Pituitary Adenomas

  2009cites this paper
• Pituitary gland and β-catenin signaling: from ontogeny to oncogenesis

  2008cites this paper
• Clinicopathological Features of Growth Hormone-producing Pituitary Adenomas: Difference among Various Types Defined by Cytokeratin Distribution Pattern Including a Transitional Form

  2008cites this paper
• Abundant hypermethylation of SOCS-1 in clinically silent pituitary adenomas

  2006cites this paper
• Evaluation Of The Relationship Between Intraoperative Tumor Consistency And Histopathological Subtypes In Patients With Acromegaly: A Prospective Single-Center Study

  year unknowncites this paper